中国耳聋患者GJB2 c.109G>A变异频率的系统评价与Meta分析
Objective: This study aims to systematically evaluate the frequency and geographic distribution of the GJB2 c.109G>A (p.Val37Ile) variant in the Chinese patients with hearing loss, providing a data-driven basis for hereditary hearing loss prevention and control.…
要点
- 中国耳聋患者GJB2 c.109G>A总体携带率11.2%,等位基因频率6.7%。
- 南方携带率16.0%显著高于北方3.4%(P<0.05)。
- 该变异频率呈南高北低分布,可为区域听力保健策略提供依据。
核心结论
- GJB2 c.109G>A在中国耳聋人群中具有较高携带率和等位基因频率,且存在显著南高北低的地域分布特征。
主要发现
- 中国耳聋患者GJB2 c.109G>A总体携带率为11.2%(95%CI:8.8%~13.7%),等位基因频率为6.7%(95%CI:5.0%~8.3%)。
- 南方携带率为16.0%(95%CI:12.3%~19.8%),等位基因频率为10.5%(95%CI:7.5%~13.4%)。
- 北方携带率为3.4%(95%CI:2.5%~4.3%),等位基因频率为2.0%(95%CI:1.5%~2.6%)。
- 南方变异频率显著高于北方(P<0.05)。
关键数值与推荐
- GJB2 c.109G>A总体携带率11.2%(95%CI:8.8%~13.7%),等位基因频率6.7%(95%CI:5.0%~8.3%)。
- 南方携带率16.0%(95%CI:12.3%~19.8%),等位基因频率10.5%(95%CI:7.5%~13.4%)。
- 北方携带率3.4%(95%CI:2.5%~4.3%),等位基因频率2.0%(95%CI:1.5%~2.6%)。
临床怎么用
- 为耳聋遗传筛查和咨询提供参考,尤其应关注南方人群该变异较高的携带率。
- 可为制定区域性的听力保健策略提供循证依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: This study aims to systematically evaluate the frequency and geographic distribution of the GJB2 c.109G>A (p.Val37Ile) variant in the Chinese patients with hearing loss, providing a data-driven basis for hereditary hearing loss prevention and control. Methods: A comprehensive literature search was conducted across seven databases-PubMed, Embase, Science Direct, Cochrane Library, Chinese Biomedical Literature Database, China National Knowledge Infrastructure and Wanfang Data System-from their inception to May 31, 2025. Studies were screened based on predefined inclusion and exclusion criteria. Data analysis was performed using R 4.4.2. Meta-analysis was applied to calculate the variant carrier rate, allele frequency, and corresponding 95% confidence intervals of GJB2 c.109G>A (p.Val37Ile). Funnel plots and Egger's test were employed to assess publication bias. Results: A total of 53 studies were included, covering 28 430 individuals with hearing loss across 17 provinces in China. Meta-analysis showed that the overall carrier rate of the GJB2 c.109G>A (p.Val37Ile) variant was 11.2% (95%CI: 8.8%-13.7%), and the allele frequency was 6.7% (95%CI: 5.0%-8.3%) in the Chinese patients with hearing loss. Subgroup analysis found that the variant frequency in southern China was significantly higher than in northern China (P<0.05). The carrier rate in southern Chinese was 16.0% (95%CI: 12.3%-19.8%),that with an allele frequency of 10.5% (95%CI: 7.5%-13.4%). In northern China, the carrier rate was 3.4% (95%CI: 2.5%-4.3%), with an allele frequency of 2.0% (95%CI: 1.5%-2.6%). Conclusions: The GJB2 c.109G>A (p.Val37Ile) variant exhibits a relatively high carrier rate and allele frequency among the Chinese patients with hearing loss, with a significant regional distribution pattern from south to north. This finding not only provides an important reference for genetic screening and counseling of hearing loss, but also offers evidence-based support for developing regional hearing health strategies. 目的: 系统评估中国耳聋患者中GJB2 c.109G>A(p.Val37Ile)的变异频率及其地域分布特征,为遗传性聋的防控提供循证依据。 方法: 检索Pubmed、Embase、Science Direct、Cochrane Library、中国生物医学文献数据库、中国期刊全文数据库、万方数据资源系统共7个数据库,时间为建库至2025年5月31日。按照纳入排除标准筛选文献,使用R软件(4.4.2版)进行数据分析,通过Meta分析计算GJB2 c.109G>A(p.Val37Ile)变异的携带率、等位基因频率及95%置信区间,采用漏斗图及Egger检验评估发表偏倚。 结果: 共纳入53项研究,覆盖中国17个省份共计28 430人。Meta分析显示,中国耳聋患者GJB2 c.109G>A(p.Val37Ile)变异的总体携带率为11.2%(95%CI:8.8%~13.7%),等位基因频率为6.7%(95%CI:5.0%~8.3%)。亚组分析发现中国南方的变异频率显著高于中国北方(P<0.05);中国南方人的携带率为16.0%(95%CI:12.3%~19.8%),等位基因频率为10.5%(95%CI:7.5%~13.4%);而中国北方人的携带率为3.4%(95%CI:2.5%~4.3%),等位基因频率为2.0%(95%CI:1.5%~2.6%)。 结论: GJB2 c.109G>A(p.Val37Ile)在中国耳聋人群中具有较高的携带率和等位基因频率,且存在显著的南高北低的地域分布特征。该发现不仅为耳聋的遗传筛查和咨询提供参考,也可为制定区域性的听力保健策略提供循证依据。.
引用
- Zhang J, Wang WJ, Liu CY, et al. [Variant frequency of GJB2 c.109G>A (p.Val37Ile) in Chinese patients with hearing loss: a systematic review and Meta-analysis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2026. PMID: 41956762. doi:10.3760/cma.j.cn115330-20250718-00380
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。